AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies

Contributed by: Business Wire

Tags

Research

Medical Supplies

FDA

Clinical Trials

Health Technology

Biotechnology

Health

Science

Oncology

Crown Bioscience

More Like This

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Crown Bioscience Appoints John Gu as Chief Executive Officer